Martyna Lis

Katowice, SL, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Disease-modifying treatment for multiple sclerosis in Poland in a European context: current practices and therapeutic strategies.

Disease-modifying treatment for multiple sclerosis in Poland in a European context: current practices and therapeutic strategies.

Journal: Neurologia i neurochirurgia polska

Published: December 18, 2025

Comparative Effects of Vitamin D Supplementation on Oxidative Stress in Relapsing-Remitting Multiple Sclerosis.

Comparative Effects of Vitamin D Supplementation on Oxidative Stress in Relapsing-Remitting Multiple Sclerosis.

Journal: Current issues in molecular biology

Published: November 01, 2024

Serum Vitamin D3 as a Potential Biomarker for Neuronal Damage in Smoldering Multiple Sclerosis.

Serum Vitamin D3 as a Potential Biomarker for Neuronal Damage in Smoldering Multiple Sclerosis.

Journal: International journal of molecular sciences

Published: September 08, 2024

Can Vitamin D Reduce Inflammation? The Influence of Supplementation on Selected Immunological Markers.

Can Vitamin D Reduce Inflammation? The Influence of Supplementation on Selected Immunological Markers.

Journal: International journal of molecular sciences

Published: May 20, 2024

Can Vitamin D Supplementation Improve Inflammation in Relapsing-Remitting Multiple Sclerosis Patients?

Can Vitamin D Supplementation Improve Inflammation in Relapsing-Remitting Multiple Sclerosis Patients?

Journal: Biomedicines

Published: May 18, 2024

The level of cytokines in tears as a novel indicator of demyelinating diseases.

The level of cytokines in tears as a novel indicator of demyelinating diseases.

Journal: Neurological research

Published: April 11, 2024

Calcium-phosphate homeostasis in secondary progressive multiple sclerosis patients during mitoxantrone therapy.

Calcium-phosphate homeostasis in secondary progressive multiple sclerosis patients during mitoxantrone therapy.

Journal: Neurological research

Published: July 09, 2021

Atrial fibrillation as an important clinical condition of cognitive decline; diagnosis, comorbidities and severity of symptoms in patients with dementia.

Atrial fibrillation as an important clinical condition of cognitive decline; diagnosis, comorbidities and severity of symptoms in patients with dementia.

Journal: Neurological research

Published: March 12, 2020

Showing 1-8 of 8

Last Updated: 09/26/2026